NE1-ELITE
LIVE

Serial Number

79246605

Owner

Invictus Biotechnology Pty Ltd

Attorney

Lindsay J. Hulley

Filing Date

Sep 18, 2018

Add to watchlist:

No watchlists yet
View on USPTO

NE1-ELITE Trademark

Serial Number: 79246605 • Registration: 5899596

NE1-ELITE is a trademark filed by Invictus Biotechnology Pty Ltd on September 18, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Invictus Biotechnology Pty Ltd (4 trademarks)

C/- ALM Williams Partners
MELBOURNE VIC 3004 , AU

Entity Type: 99

Trademark Details

Filing Date

September 18, 2018

Registration Date

November 5, 2019

Published for Opposition

August 20, 2019

Goods & Services

Dietary food supplements; dietary nutritional supplements; dietary protein supplements; dietary supplements; energy drinks in the nature of dietary supplement drinks; herbal dietary supplements; plant compounds for use as dietary supplements for medicinal purposes; plant extracts sold as components of dietary supplements; protein dietary supplements; dietetic food supplements adapted for medical purposes; food supplements for medical purposes; medicated food supplements; medicated preparations for use as supplements for food; medicated supplements for food; medicated supplements for foodstuffs for human consumption; medicinal food supplements; nutritional supplements; nutritional supplements for medical use; protein supplements for humans; nutritional supplements containing trace elements for foodstuffs for human consumption; vitamin preparations in the nature of food supplements; vitamin supplements; vitamin supplements for foodstuffs for human consumption; preparations of vitamins; stimulants made of vitamins for improving exercise performance; vitamin drinks, namely, dietary supplemental drinks in the nature of vitamin beverages; vitamin preparations; vitamin preparations for human consumption; vitamin preparations in tablet form; vitamin tablets; vitamins; capsules sold empty for medicines; medicines for muscle injuries and disorders and sports related injuries and for improving exercise endurance, capacity and performance for human purposes; medicines for human use for muscle injuries and disorders and sports related injuries and for improving exercise endurance, capacity and performance; medicines for preventing muscle injuries and disorders and sports related injuries ailments; medicines for treatment of the heart; medicinal preparations for the mouth to be applied in the form of tablets; tablets for medicines, namely, drug delivery agents in the form of tablets that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations in the form of tablets for the prevention of muscle injuries and disorders and sports related injuries; pharmaceutical preparations in the form of tablets for improving exercise endurance, capacity and performance; pharmaceutical tablets for muscle injuries and disorders and sports related injuries and for improving exercise endurance, capacity and performance; specialized tablets for the delivery of pharmaceuticals sold without the pharmaceutical ingredient

Filing History

TEAS SECTION 71 & 15 RECEIVED
May 5, 2026 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 5, 2024 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 20, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 1, 2020 FICS
FINAL DISPOSITION PROCESSED
Feb 29, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 5, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 5, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 20, 2019 NPUB
PUBLISHED FOR OPPOSITION
Aug 20, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Aug 16, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 31, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 31, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 31, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 18, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 18, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 18, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 18, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 18, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 3, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 3, 2019 CRFA
ASSIGNED TO LIE
Jul 1, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 27, 2019 TROA
REFUSAL PROCESSED BY IB
Feb 8, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 18, 2019 RFCS
REFUSAL PROCESSED BY MPU
Jan 17, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 8, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jan 7, 2019 CNRT
ASSIGNED TO EXAMINER
Dec 28, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 4, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 30, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 29, 2018 REPR